Why We Age
Viral Shockwave

clinicaltrialist.com

Drug Development
A New Look at Biology
Managing Startups
- Management
- Managing A Public Company
Links & Info
Orthogonal Concepts
- Phase Transition
- Black Swan
About
- About Me
- Contact

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Search for:

Blog Posts

My Textbooks

Principles and Practice of Clinical Trial Medicine
Global Clinical Trials
Global Clinical Trials Playbook
Adaptive and Flexible Clinical Trials

Clinical Trialists I've Trained

Sheila Gujrathi, Chief Executive Officer at Gossamer Bio
Naveed Shams, Head of Global R&D and Chief Scientific Officer, Santen
June Lee, Chief Operating Officer at MyoKardia
Charlie Semba, Chief Medical Officer at Graybug Vision
Sunil Agarwal, President of Research and Development Juno Therapeutics
Robert Kim, Chief Medical Officer at Apellis Pharmaceuticals
Yamo Deniz, Former Chief Medical Office at GE Healthcare Diagnostics
Paul Kwon, Chief Medical Officer at Menlo Therapeutics
Elena Hitraya, Chief Medical Officer at Crescendo Bioscience
Wolfgang Dummer, Former Vice President of Clinical Science, Biomarin
Paul Brunetta, Senior Vice President, Translational Sciences at Juno Therapeutics

About Me

Richard Chin is the Founder and CEO of KindredBio (NASDAQ:KIN), a biotech company developing drugs for companion animals. He is also an Associate Professor at UCSF, where he teaches drug development. His expertise is in clinical development and he has authored several books on clinical trials. More

The posts and opinions on this site are my own and do not necessarily represent those of KindredBio.

Nothing on this blog is medical advice. Do what your doctor tells you to do. Do not do anything she tells you not to do.

Find us on

Blog at WordPress.com.